We are live on ! Find out more
ACET icon

Adicet Bio

54 hedge funds and large institutions have $41.6M invested in Adicet Bio in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

32% more capital invested

Capital invested by funds: $31.5M → $41.6M (+$10.2M)

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

10% more funds holding

Funds holding: 4954 (+5)

0.04% less ownership

Funds ownership: 3.9%3.86% (-0.04%)

Holders
54
Holders Change
+5
Holders Change %
+10.2%
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
12
Increased
13
Reduced
11
Closed
7
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$16K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$625
ASN
52
Advisory Services Network
Georgia
$256 +$236 +20 New
Citigroup
53
Citigroup
New York
$134 -$401 -34 -77%
Osaic Holdings
54
Osaic Holdings
Arizona
$7 +$12 +1 New
DCM
55
DAFNA Capital Management
California
-$329K -33,750 Closed
LM
56
Luminus Management
Texas
-$177K -18,121 Closed
Charles Schwab
57
Charles Schwab
California
-$18.3K -1,875 Closed
D.E. Shaw & Co
58
D.E. Shaw & Co
New York
-$13.5K -1,387 Closed
LCM
59
Landscape Capital Management
New Jersey
-$10.9K -1,115 Closed
RAM
60
Riggs Asset Management
Pennsylvania
-$685 -70 Closed
Simplex Trading
61
Simplex Trading
Illinois
-$424 -36 Closed

ACET Hedge Fund Activity: Q3 2025 in Review

54 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q3 2025, worth a combined $41.6M — up 32% from $31.5M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ACET positions and 7 closed out — a net gain of 5 holders — while 13 added to existing stakes and 11 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $497K. The largest seller was Schonfeld Strategic Advisors, cutting an estimated $1.03M.

  • 54 institutional investors held Adicet Bio (ACET) as of Q3 2025, up from 49 in Q2 2025.
  • Funds reported $41.6M of Adicet Bio stock for Q3 2025, up 32% quarter-over-quarter.
  • 12 funds opened new Adicet Bio positions in Q3 2025 and 7 closed out, a net change of +5 holders.
  • The largest Adicet Bio buyer in Q3 2025 was Renaissance Technologies, an estimated $497K added.
  • The largest Adicet Bio seller in Q3 2025 was Schonfeld Strategic Advisors, an estimated $1.03M sold.

Based on aggregated 13F filings for Q3 2025.